Skip to content

Clinical study of nonsurgical periodontal therapy on insulin resistance in patients with diabetes periodontitis

Effect of nonsurgical periodontal therapy on insulin resistance in patients with diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099776
Enrollment
Unknown
Registered
2025-03-28
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, diabetes

Interventions

Control group:Oral Hygiene Instruction
Experimental group:Nonsurgical periodontal therapy

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>=18 years; 2. Patients with a diagnosis of T2DM based on the 2013 American Diabetes Association diagnostic criteria for T2DM and who were diagnosed with T2DM at least 6 months prior to inclusion, 6.5% remaining teeth in the mouth = 20, and no periodontal treatment has been performed in the past 6 months; 4. The patient's diet and exercise remained basically unchanged during the observation period; 5. BMI of women is 19-26 kg/m^2, and BMI of men is 20-27 kg/m^2; 6. Have not taken antibiotics or non-steroidal anti-inflammatory drugs in the past 3 months.

Exclusion criteria

Exclusion criteria: 1. Edentulous patients; 2. Patients with severe infection or severe trauma; 3. Severe systemic disease or complication, with systemic inflammatory diseases (such as rheumatoid arthritis, etc.). , patients with hematologic diseases, liver damage, kidney disease, and immune insufficiency; 4. Alcoholism or chronic drug abuse; 5. Smoking; 6. Physical or mental impairment that interferes with oral health care; 7. Pregnant or lactating women; 8. Long-term use of related drugs that may lead to gingival hyperplasia; 9. Patients who believe that the investigator has poor compliance and cannot participate in the trial.

Design outcomes

Primary

MeasureTime frame
Clinical indicators related to insulin resistance (islet resistance index HOMA-IR, serum adiponectin, inflammatory factors, glycolipid metabolism);

Secondary

MeasureTime frame
Periodontal clinical indices (probing depth PD, loss of attachment AL, bleeding index BI, and plaque index PLI);

Countries

China

Contacts

Public ContactLi Mengdi

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

442816685@qq.com+86 21 53315510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026